Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments

Severe asthma and the omalizumab option

Christopher WT Miller email, Narayanaswamy Krishnaswamy email, Chambless Johnston email and Guha Krishnaswamy email

Clinical and Molecular Allergy 2008, 6:4doi:10.1186/1476-7961-6-4

No comments have yet been made on this article

Post a comment


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.